Opinion of Pollen Preparations Manufactured by AB Cernelle
by Lars-Erik Essen M. D.
Specialist in: Dermatological Diseases, Venereal Diseases, Internal Diseases
Address: Kullagatan 58, Halsingborg, Sweden
Pollen preparations containing Cernitin™
Some new types of pollen preparations have been introduced by AB
Cernelle, Vegeholm, Sweden. These substances are based on Cernitin™, a microbiologically
digested extract of raw pollen. In my opinion, these preparations are worthy of special
interest since they have been found to offer possibilities of treating pathological
conditions which, to date, have not been associated with, or constituted indications for,
this type of substance. Some of these indications have been recognized as a result of
recent research, which has led to the discovery of active substances in the different
pollen fractions.
In private practice, caution must be exercised in drawing definite conclusions from the
results of therapy with these preparations, as it is not possible to test them under
isolated conditions and without other medication, since in each individual case they
must be combined with some other suitable treatment. However, preliminary studies in
my own practice have given me the undeniable impression that these substances, which
were also employed against indications not previously recognized as being responsive
to this therapy, proved to be satisfactory adjuvants in the treatment of a number of
diseases, e.g.: ulcers diseases, certain forms of infections of the urinary tract,
nonspecific urethritis, some types of headaches and, tentatively, even migraine. Further,
they served as good general roborant agents both in asthenic and neurasthenic states,
particularly during convalescence, and exhibited effects, which were frequently
remarkable. In this connection, I wish to emphasize particularly that, in my opinion,
these substances are highly valuable as tonics in geriatric praxis. I have been able to
note a double psychosomatic effect in geriatric patients. Treatment with these
substances was introduced in cases of mild senile dementia induced by arteriosclerosis, and in senile depression. I was able to confirm that, in parallel with an
improved somatic state, there was a return - of mental powers such as the ability to
orientate, to remember and to concentrate, and that in the course of time depressions
were mitigated. These results led quite naturally to the thought that pollen preparations
might possibly be indicated, at least as adjuvant, in the treatment of milder mental
disturbances and psychoses since they might have a favorable effect on the cerebral
metabolism at least insofar as a disturbed cerebral metabolism can be regarded as the
etiological background of these conditions. On the basis of these indications, I am at
present prescribing the preparations for this category of patients. The experiments
appear to be giving satisfactory results although the duration of treatment is still too
short to permit any definite conclusions. When time permits, I shall provide a report on
these experiments but I would like to mention them in passing as they might offer a
stimulus to others to investigate further. Another point, which I find especially
noteworthy, is the prophylactic properties shown by these substances in infections,
both bacterial and virus, and their action here being to boost the general resistance of
the organism. Further, there appears to be a mitigating effect on infections, which have
already passed their peak. Thus, patients showing a marked tendency to relapse in
different types of infectious diseases have noted that, after a period of regular therapy
with pollen preparations of the type referred to here, this tendency frequently becomes
less emphatic and, in some cases, even disappears completely. It has been stated that
the preparations are valuable in the treatment of prostatitis and hepatitis. However, I
have not yet had an opportunity of verifying this in my own practice.
In my capacity as dermatologist, I have found these substances to be of value for topical
treatment in cosmetic dermatological praxis. Suppressive effects in facial acne and
previously confirmed effects in healing and the treatment of burns are of interest, but
until I have been able to follow up therapy on an extensive scale, I cannot permit myself
to pass judgment.
Obviously, the material upon which these preliminary observations are based is not
sufficiently large to permit definite conclusions but, on the other hand, some of the
results are so noteworthy and emphatic that they encourage continued and more
extensive research.
The initiative taken by AB Cernelle in introducing these pollen preparations and the
associated research performed by this company is, in my opinion, particularly important
at a time when the pharmaceutical industry is devoted almost entirely to the production
of synthetic drugs. Far-sighted scientists are agreed that this single-mindedness can, in
the long run, lead to catastrophic results in human immunobiology, and they are also
deeply concerned about the present wide-spread misuse in suppressing or substituting,
on almost every occasion, the natural protective and defense reactions of the body. Our
lack of knowledge in this field, and our short sightedness, frequently leads us to be
stupidly generous in handling the enormous arsenal of antibiotics and chemotherapeutics at present at our disposal. In the face of this situation, every attempt
to revert to more "natural" and biologically attuned preparations must be welcomed.
From this point of view, it is particularly satisfying to be able to acknowledge the
research and the introduction of more biologically related substances presented by AB
Cernelle.
Halsingborg, 30th June, 1959
LARS-ERIK ESSEN, M.D.